Featured Speakers

• 

  Klaus PantelDirector, Institute of Tumour Biology University Hamburg

• 

  Thomas KrahnHead, Global Biomarker Research Bayer

• 

  Jean MaralSenior Director Sanofi

• 

  Sonia QuaratinoSenior Medical Director Merck Serono

How advances in CTC technologies can dramatically improve patient diagnosis and decision making

Download Brochure | Register Now

Hailed as the ‘liquid biopsy’, CTCs represent the future of non-invasive testing.

If you are reading this then you already know about the huge potential of CTCs in both drug development and the clinical setting.

The next key step to fuel progress in the field lies in examining clinical case studies where CTCs are used as routine diagnostic and prognostic tools. The 4th World Circulating Tumour Cell Summit brought together the leading drug developers, technology providers and clinicians to discuss these challenges. They discussed how CTCs can be practically applied as surrogate clinical endpoints, which detection technologies hold the most promise, and how they can be used to aid cost effective drug development.

Imagine yourself in a room crowded full of thought leaders from organisations whose primary goal is to further the use of CTCs in drug development & see this field expand into the clinic. Because that is exactly what happened in Berlin in April.

Attendees of the 2012 meeting:

• Learned how industry is moving away from enumeration and using characterisation of CTCs to improve clinical decision making from Genentech and Medimmune
• Discovered how to effectively incorporate CTCs into the clinic to asses treatment efficacy with Munich University Hospital, University Hospital Montpellier, Patterson Institute for Cancer Research, Medical University Graz
• Gained an understanding on the hurdles that CTC assays must overcome so they could be used to improve clinical management of patients with expert insight from Klaus Pantel
• Obtained a pharma perspective from AstraZeneca, Bayer, Genentech, & Sanofi on the potential utility of CTCs for personalising oncology drug development
• Received an unbiased analysis of the advantages and disadvantages of the various rapidly-evolving technical platforms so you can assess where to best spend your valuable R&D budget

Who Attended?

The World Circulating Tumour Cells Series feature the world’s only commercial meetings focusing exclusively on developing your understanding of how to utilise CTC technologies. The Europe meeting was designed to provide invaluable insights into the development of new technologies and crucially how they are being used in the clinic. 

This meant it was for:

• Basic Researcher looking at optimising approaches to CTC detection, capture and characterisation
• Clinicians keen to understand the progress of other clinical studies and advances in CTC research
• Technology Specialists seeking to highlight novel platforms and equipment
• Diagnostics Players exploring the potential of CTCs for prognosis and diagnosis
• Regulators, Reimbursers & Consultants working in the IVD regulatory landscape

Hear what attendee's had to say about this year's meeting in San Diego: 

“I really enjoyed the wealth of knowledge on CTCs. The networking session was of great benefit. As a person new to CTC, it was wonderful networking with  attendees”

Pfizer

“Very useful meeting, great for networking and knowing what every company in the field is doing”  

Rarecyte

“Opportunities for individuals interested in CTCs to meet, discuss, and learn the latest technology and progress of CTC’s”

Biocept

“Hanson Wade continued their excellent organization skills, and the focus towards making innovative fields and technologies more and more visable”

Baylor College of Medicine

 “A nice balance of vendors, clinicians and researchers in well established as well as emerging companies. Very useful for key contacts”

Biofluidica Microtechnologies

What’s next?

Look out for the draft agenda for the 2013 meeting - we will be releasing it soon!

Stay updated by joining the LinkedIn community. Search “Circulating Tumour Cells Forum"

Something you want to share; white papers, articles or interested in speaking? Then let us know... just email any questions to info@hansonwade.com